Blue diaper syndrome
diseaseOn this page
Also known as Drummond syndromefamilial hypercalcemia-nephrocalcinosis-indicanuria syndrome
Summary
Blue diaper syndrome (MONDO:0008877) is a disease. A subtype of inborn disorder of amino acid transport — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide)
- Phenotypes (HPO): 12
Clinical features
Signs & symptoms
Clinical features (HPO)
12 HPO clinical features (Orphanet curated; top 12 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0040317 | Blue urine | Very frequent (80-99%) |
| HP:0000121 | Nephrocalcinosis | Frequent (30-79%) |
| HP:0002014 | Diarrhea | Frequent (30-79%) |
| HP:0003072 | Hypercalcemia | Frequent (30-79%) |
| HP:0004324 | Increased body weight | Frequent (30-79%) |
| HP:0001942 | Metabolic acidosis | Occasional (5-29%) |
| HP:0001988 | Recurrent hypoglycemia | Occasional (5-29%) |
| HP:0002905 | Hyperphosphatemia | Occasional (5-29%) |
| HP:0002910 | Elevated circulating hepatic transaminase concentration | Occasional (5-29%) |
| HP:0002925 | Elevated circulating thyroid-stimulating hormone concentration | Occasional (5-29%) |
| HP:0031507 | Decreased circulating thyroxine level | Occasional (5-29%) |
| HP:0031883 | Increased proinsulin:insulin ratio | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | blue diaper syndrome |
| Mondo ID | MONDO:0008877 |
| MeSH | C536239 |
| OMIM | 211000 |
| Orphanet | 94086 |
| ICD-11 | 292681007 |
| SNOMED CT | 59531002 |
| UMLS | C0268478 |
| MedGen | 75685 |
| GARD | 0005939 |
| NORD | 864 |
| Is cancer (heuristic) | no |
Also known as: blue diaper syndrome · Drummond syndrome · familial hypercalcemia-nephrocalcinosis-indicanuria syndrome
Disease family
This is a subtype of inborn disorder of amino acid transport. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › inborn errors of metabolism › inborn disorder of amino acid and other organic acid metabolism › inborn disorder of amino acid metabolism › inborn disorder of amino acid transport › blue diaper syndrome
Related subtypes (18): ocular cystinosis, juvenile nephropathic cystinosis, cystinuria, hyperdibasic aminoaciduria type 1, lysinuric protein intolerance, dicarboxylic aminoaciduria, Hartnup disease, histidinuria due to a renal tubular defect, iminoglycinuria, oculocerebrorenal syndrome, hypotonia-cystinuria syndrome, foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome, episodic ataxia type 6, progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome, disorder of neutral amino acid transport, autosomal recessive cerebellar ataxia - pyramidal signs - nystagmus - oculomotor apraxia syndrome, nephropathic infantile cystinosis, undetermined early-onset epileptic encephalopathy
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.